{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T07:21:52Z","timestamp":1778224912415,"version":"3.51.4"},"reference-count":26,"publisher":"The Company of Biologists","issue":"11","license":[{"start":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T00:00:00Z","timestamp":1599004800000},"content-version":"vor","delay-in-days":1797,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,11,15]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:p>Tryptophan metabolites have been linked in observational studies with type 2 diabetes, cognitive disorders, inflammation and immune system regulation. A rate-limiting enzyme in tryptophan conversion is arylformamidase (Afmid), and a double knockout of this gene and thymidine kinase (Tk) has been reported to cause renal failure and abnormal immune system regulation. In order to further investigate possible links between abnormal tryptophan catabolism and diabetes and to examine the effect of single Afmid knockout, we have carried out metabolic phenotyping of an exon 2 Afmid gene knockout. These mice exhibit impaired glucose tolerance, although their insulin sensitivity is unchanged in comparison to wild-type animals. This phenotype results from a defect in glucose stimulated insulin secretion and these mice show reduced islet mass with age. No evidence of a renal phenotype was found, suggesting that this published phenotype resulted from loss of Tk expression in the double knockout. However, despite specifically removing only exon 2 of Afmid in our experiments we also observed some reduction of Tk expression, possibly due to a regulatory element in this region. In summary, our findings support a link between abnormal tryptophan metabolism and diabetes and highlight beta cell function for further mechanistic analysis.<\/jats:p>","DOI":"10.1242\/bio.013342","type":"journal-article","created":{"date-parts":[[2015,10,2]],"date-time":"2015-10-02T23:59:04Z","timestamp":1443830344000},"page":"1367-1375","source":"Crossref","is-referenced-by-count":14,"title":["Loss of arylformamidase with reduced thymidine kinase expression leads to impaired glucose tolerance"],"prefix":"10.1242","volume":"4","author":[{"given":"Alison J.","family":"Hugill","sequence":"first","affiliation":[{"name":"Mammalian Genetics Unit, Medical Research Council Harwell, Oxford, Oxfordshire OX11 0RD, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle E.","family":"Stewart","sequence":"additional","affiliation":[{"name":"Mary Lyon Centre, Medical Research Council Harwell, Oxford, Oxfordshire OX11 0RD, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne A.","family":"Yon","sequence":"additional","affiliation":[{"name":"Mammalian Genetics Unit, Medical Research Council Harwell, Oxford, Oxfordshire OX11 0RD, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fay","family":"Probert","sequence":"additional","affiliation":[{"name":"Mary Lyon Centre, Medical Research Council Harwell, Oxford, Oxfordshire OX11 0RD, UK"},{"name":"Institute of Hepatology, Foundation for Liver Research, 69-75 Chenies Mews, London WC1E 6HX, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I. Jane","family":"Cox","sequence":"additional","affiliation":[{"name":"Institute of Hepatology, Foundation for Liver Research, 69-75 Chenies Mews, London WC1E 6HX, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tertius A.","family":"Hough","sequence":"additional","affiliation":[{"name":"Mary Lyon Centre, Medical Research Council Harwell, Oxford, Oxfordshire OX11 0RD, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheryl L.","family":"Scudamore","sequence":"additional","affiliation":[{"name":"Mary Lyon Centre, Medical Research Council Harwell, Oxford, Oxfordshire OX11 0RD, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liz","family":"Bentley","sequence":"additional","affiliation":[{"name":"Mammalian Genetics Unit, Medical Research Council Harwell, Oxford, Oxfordshire OX11 0RD, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Wall","sequence":"additional","affiliation":[{"name":"Mammalian Genetics Unit, Medical Research Council Harwell, Oxford, Oxfordshire OX11 0RD, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara E.","family":"Wells","sequence":"additional","affiliation":[{"name":"Mary Lyon Centre, Medical Research Council Harwell, Oxford, Oxfordshire OX11 0RD, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger D.","family":"Cox","sequence":"additional","affiliation":[{"name":"Mammalian Genetics Unit, Medical Research Council Harwell, Oxford, Oxfordshire OX11 0RD, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"237","published-online":{"date-parts":[[2015,10,2]]},"reference":[{"key":"2021042423202789500_BIO013342C1","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1007\/s00335-012-9422-2","article-title":"The mammalian gene function resource: the International Knockout Mouse Consortium","volume":"23","author":"Bradley","year":"2012","journal-title":"Mamm. Genome"},{"key":"2021042423202789500_BIO013342C2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1096-7192(02)00224-X","article-title":"Mice deficient for cytosolic thymidine kinase gene develop fatal kidney disease","volume":"78","author":"Dobrovolsky","year":"2003","journal-title":"Mol. Genet. Metab."},{"key":"2021042423202789500_BIO013342C3","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.bbagen.2005.03.010","article-title":"Effect of arylformamidase (kynurenine formamidase) gene inactivation in mice on enzymatic activity, kynurenine pathway metabolites and phenotype","volume":"1724","author":"Dobrovolsky","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"2021042423202789500_BIO013342C4","first-page":"221","article-title":"Studies on the urinary excretion of xanthurenic acid in diabetics","volume":"6","author":"Hattori","year":"1984","journal-title":"Acta Vitaminol. Enzymol."},{"key":"2021042423202789500_BIO013342C5","first-page":"232","article-title":"Urinary-excretion of xanthurenic acid and zinc in diabetes .3. Occurrence of Xanthurenic acid-Zn-2+ complex in urine of diabetic-patients and of experimentally-diabetic rats","volume":"35","author":"Ikeda","year":"1986","journal-title":"Ital. J. Biochem."},{"key":"2021042423202789500_BIO013342C6","first-page":"236","article-title":"Abnormal tryptophan-metabolism and experimental diabetes by Xanthurenic acid (Xa)","volume":"29","author":"Kotake","year":"1975","journal-title":"Acta Vitaminol. Enzymol."},{"key":"2021042423202789500_BIO013342C7","doi-asserted-by":"publisher","first-page":"10592","DOI":"10.1523\/JNEUROSCI.1107-14.2014","article-title":"Reduction of brain kynurenic acid improves cognitive function","volume":"34","author":"Kozak","year":"2014","journal-title":"J. Neurosci."},{"key":"2021042423202789500_BIO013342C8","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.cell.2014.12.028","article-title":"Kynurenic acid is a nutritional cue that enables behavioral plasticity","volume":"160","author":"Lemieux","year":"2015","journal-title":"Cell"},{"key":"2021042423202789500_BIO013342C9","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/j.1600-065X.2012.01149.x","article-title":"Amino acid catabolism: a pivotal regulator of innate and adaptive immunity","volume":"249","author":"McGaha","year":"2012","journal-title":"Immunol. Rev."},{"key":"2021042423202789500_BIO013342C10","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3109\/13813455.2011.623705","article-title":"Evaluation of indoleamine 2,3-dioxygenase expression and kynurenine pathway metabolites levels in serum samples of diabetic retinopathy patients","volume":"117","author":"Munipally","year":"2011","journal-title":"Arch. Physiol. Biochem."},{"key":"2021042423202789500_BIO013342C11","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/BF02590750","article-title":"Inhibition by kynurenine metabolites of proinsulin synthesis in isolated pancreatic-islets","volume":"15","author":"Noto","year":"1978","journal-title":"Acta Diabetol. Latina"},{"key":"2021042423202789500_BIO013342C12","first-page":"227","article-title":"Effect of quinaldic acid and its relatives on insulin-release from isolated Langerhans islets","volume":"29","author":"Okamoto","year":"1975","journal-title":"Acta Vitaminol. Enzymol."},{"key":"2021042423202789500_BIO013342C13","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/s12035-013-8497-4","article-title":"Insulin resistance and dysregulation of tryptophan-kynurenine and kynurenine-nicotinamide adenine dinucleotide metabolic pathways","volume":"48","author":"Oxenkrug","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"2021042423202789500_BIO013342C14","doi-asserted-by":"publisher","first-page":"149247","DOI":"10.1155\/2013\/149247","article-title":"Tryptophan-kynurenine metabolism and insulin resistance in hepatitis C patients","volume":"2013","author":"Oxenkrug","year":"2013","journal-title":"Hepat. Res. Treat."},{"key":"2021042423202789500_BIO013342C15","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0167-4838(02)00232-7","article-title":"Kynurenine formamidase: determination of primary structure and modeling-based prediction of tertiary structure and catalytic triad","volume":"1596","author":"Pabarcus","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"2021042423202789500_BIO013342C16","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.pep.2005.04.013","article-title":"Cloning, expression, and catalytic triad of recombinant arylformamidase","volume":"44","author":"Pabarcus","year":"2005","journal-title":"Protein Expr. Purif."},{"key":"2021042423202789500_BIO013342C17","doi-asserted-by":"publisher","first-page":"19511","DOI":"10.1074\/jbc.M111.221739","article-title":"Metabolomics reveals attenuation of the SLC6A20 kidney transporter in nonhuman primate and mouse models of type 2 diabetes mellitus","volume":"286","author":"Patterson","year":"2011","journal-title":"J. Biol. Chem."},{"key":"2021042423202789500_BIO013342C18","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nmeth.1342","article-title":"Agouti C57BL\/6N embryonic stem cells for mouse genetic resources","volume":"6","author":"Pettitt","year":"2009","journal-title":"Nat. Methods"},{"key":"2021042423202789500_BIO013342C19","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3181\/00379727-178-42010","article-title":"3-Hydroxykynurenine, 3-hydroxyanthranilic acid, and o-aminophenol inhibit leucine-stimulated insulin release from rat pancreatic islets","volume":"178","author":"Rogers","year":"1985","journal-title":"Exp. Biol. Med."},{"key":"2021042423202789500_BIO013342C20","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/nature06471","article-title":"Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease","volume":"451","author":"Romani","year":"2008","journal-title":"Nature"},{"key":"2021042423202789500_BIO013342C21","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/S0076-6879(09)05025-3","article-title":"Insulin secretion from beta-cells is affected by deletion of nicotinamide nucleotide transhydrogenase","volume":"457","author":"Shimomura","year":"2009","journal-title":"Methods Enzymol."},{"key":"2021042423202789500_BIO013342C22","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature10163","article-title":"A conditional knockout resource for the genome-wide study of mouse gene function","volume":"474","author":"Skarnes","year":"2011","journal-title":"Nature"},{"key":"2021042423202789500_BIO013342C23","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/nrd870","article-title":"Endogenous kynurenines as targets for drug discovery and development","volume":"1","author":"Stone","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"2021042423202789500_BIO013342C24","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1111\/bph.12230","article-title":"The kynurenine pathway as a therapeutic target in cognitive and neurodegenerative disorders","volume":"169","author":"Stone","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"2021042423202789500_BIO013342C25","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s11306-011-0291-6","article-title":"Discovery of early-stage biomarkers for diabetic kidney disease using ms-based metabolomics (FinnDiane study)","volume":"8","author":"van der Kloet","year":"2012","journal-title":"Metabolomics"},{"key":"2021042423202789500_BIO013342C26","doi-asserted-by":"publisher","first-page":"e59749","DOI":"10.1371\/journal.pone.0059749","article-title":"Expression of tryptophan 2,3-dioxygenase and production of kynurenine pathway metabolites in triple transgenic mice and human Alzheimer's disease brain","volume":"8","author":"Wu","year":"2013","journal-title":"PLoS ONE"}],"container-title":["Biology Open"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.logists.com\/bio\/bio\/article-pdf\/4\/11\/1367\/1112817\/bio013342.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/journals.logists.com\/bio\/bio\/article-pdf\/4\/11\/1367\/1112817\/bio013342.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,24]],"date-time":"2021-04-24T23:20:35Z","timestamp":1619306435000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.biologists.com\/bio\/article\/4\/11\/1367\/1316\/Loss-of-arylformamidase-with-reduced-thymidine"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,2]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11,15]]}},"URL":"https:\/\/doi.org\/10.1242\/bio.013342","relation":{},"ISSN":["2046-6390"],"issn-type":[{"value":"2046-6390","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,2]]}}}